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Abstract 
Background: Obesity, a growing epidemic, is a preventable risk factor for cardiometabolic diseases. Obesity and cardiometabolic 
diseases affect Hispanics and African Americans more than non-Hispanic Caucasians. This study examined the relationship 
among race/ethnicity, obesity diagnostic measures (body mass index, waist circumference, subscapular and triceps skinfold 
thickness), and cardiometabolic risk factors (hyperglycemia, high, non-high-density lipoprotein cholesterol, low, high-density 
lipoprotein cholesterol, and hypertension) for adults across the United States. 
Methods: Using data from two-cycles of the National Health and Examination Survey (NHANES) 2007-2010, and accounting 
for the complex sample design, logistic regression models were conducted comparing obesity indicators in Mexican Americans, 
other Hispanics, and Black non-Hispanics, with White non-Hispanics and their associations with the presence of cardiometabolic 
diseases. 
Results: Differences by race/ethnicity were found for subscapular skinfold thickness and hyperglycemia. Waist circumference and 
subscapular skinfold were positively associated with the presence of hyperglycemia; dyslipidemia, and hypertension across race/
ethnicity, adjusting for age, gender, smoking, physical activity, education, income to poverty index, and health insurance. Race/
ethnicity did not influence the association of any obesity indicators with the tested cardiometabolic diseases. All obesity measures 
except triceps skinfold were associated with hyperglycemia. 
Conclusions: We suggest that subscapular skinfold thickness be considered as an inexpensive non-intrusive screening tool for 
cardiometabolic risk factors in an adult US population. 
Keywords: Cardiovascular diseases, diabetes, hyperglycemia, hypertension, dyslipidemia, obesity, skinfold measures, race/ethnicity
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Introduction
Obesity, 20% or more over ideal body weight, is a growing 
epidemic across race/ethnicity in the United States. From 
1960-2006, the percentage of obese adults more than doubled, 
increasing from 13% to 35% [1]. Although there was not 
an increase in obesity from 2007 to 2010 [2,3], there are 
subpopulations whose rates exceeded the average. The 
prevalence of obesity is higher in African Americans (1.4) and 
Hispanics (1.2) as compared to non-Hispanic Whites [4]. Obesity 
has been clinically defined by several measures, including 
waist circumference and body mass index (BMI). Individuals 
whose body mass index (BMI) ≥ 30 kg/m2 are considered obese 
[3,5]. Based on a recent systematic meta-analysis of US and 
international populations, obese individuals were significantly 
were associated with higher mortality as compared to normal 
weight individuals [6]. (Flegal et al., 2013). Cardiometabolic risk 
is considered with waist circumference ≥102 cm (≥40 in) for 
men and ≥88 cm (≥35 in) for women; however, there is evidence 
that these cutoffs may be lower in certain races/ethnicities [7]. 
Truncal skinfold thickness and waist circumference measures 
are considered indicators of central obesity. Skinfold thickness 
has been associated with body fatness and may be a better 
indicator of adverse health outcomes than BMI [8].
Obesity is among the major risk factors of cardiometabolic 
diseases including hyperglycemia (prediabetes/diabetes), 
hypertension and dyslipidemia [9]. Over one-quarter of a 
million premature deaths in the US per year are attributed to 
obesity [10]. The incidence of heart diseases, including diabetes, 
hypertension, and dyslipidemia, is greater for persons who are 
obese [10]. Early diagnosis and treatment depends on access 
to healthcare and uninsured persons are less-likely to receive 
medical care [11]. A higher percent of African Americans (20.8) 
and Hispanics (30.7) have no health insurance as compared to 
non-Hispanic Whites (11.7) [4]. Obesity screening methods for 
hard to reach population have not been determined. Health 
fairs and community health screenings with subscapular and 
triceps skinfold measurement may be more effective than taking 
weight, height and waist circumference. The purpose of this 
study is to assess the association of these obesity indicators 
with cardiometabolic diseases: hyperglycemia, hypertension, 
and high, non-high-density lipoprotein cholesterol (non-HDL-C), 
and low, high-density lipoprotein cholesterol (HDL-C).
Materials and methods
Source of data 
Data for this study were from appended 2-year cycles of datasets 
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from the National Health and Nutrition Examination Survey 
(NHANES) 2007-2008 and 2009-2010 [12]. NHANES uses a 
complex, multistage, probability sample design to obtain 
representative samples of the noninstitutionalized, civilian 
US population [12]. This study acquired data (N=11,377) for 
males and females ≥ 21 years of aged from four out of five 
racial/ethnic categories: Mexican Americans (MA); Other 
Hispanics (OH); Black non-Hispanics (BNH); and White non-
Hispanics (WNH). The classification ‘other races’ (Asian and 
mixed-races) was excluded since numbers in this category 
were not sufficient for multiple comparisons. The final sample 
size with data for the study variables was N=8850 (MA=1654, 
OH=1010, BNH=1591, WNH=4595).
Ethical considerations
 The data used for this study were publically available. Prior to 
public release, the study protocols (continuation of protocol 
#2005-06 for both datasets) were approved by the National 
Center for Health Statistics Research Ethics Review Board 
(NCHS-ERB) [13]. Separate informed consent forms were signed 
by participants for the interview and health examination, or 
just the interview. Participants for this study read, understood, 
and signed informed consent forms for the interview and 
health examination.
Major variables
 Independent variables included race/ethnicity and obesity 
indicators. A nominal category for race/ethnicity recoded 
for WNH as the reference. The category “other races” was 
eliminated with a filter. Waist circumference was tested 
for linearity and used as a continuous variable. Body mass 
index (BMI) was coded as an ordinal variable with four levels 
combining the World Health Organization (WHO)’s categories 
[5] as follows: underweight and normal were collapsed to 
category 1 (BMI < 25 kg/m2); category 2 corresponded to pre 
obese (BMI = 25-29.9 kg/m2); category 3 corresponded to 
obese, class I (BMI = 30-34.9 kg/m2); and, category 4 combined 
obese classes II and III (BMI ≥ 35kg/m2 ). Waist circumference 
and skinfold thickness measurements, including triceps 
and subscapular, were categorized in quartiles. Dependent 
variables were prediabetes or diabetes, dyslipidemia, and 
hypertension. The variable for hyperglycemia was computed 
by % glycated hemoglobin (A1C) ≥ 6.0, dyslipidemia, abnormal 
levels of one or more of the lipoproteins, was measured by 
low HDL-C and high, non-HDL-C ≥130 mg/dL. Cutoffs for low 
HDL-C were <40 mg/dL for men and <50 mg/dL for women 
[14]. The variable for non-HDL-C was created by subtracting 
HDL-C from total cholesterol, then computing the binary 
variable. The American Association of Clinical Endocrinologists 
(AACE) recommend non-HDL-C be less than 30mg/dL above 
the target for low-density lipoprotein cholesterol (LDL-C <100 
mg/dL) [14]. Non-HDL-C is the sum of all lipoproteins except 
HDL-C and includes LDL-C intermediate and very low-density 
lipoproteins, lipoprotein (a). A dyslipidemia score was created 
adding variables for high non-HDL-C, high triglycerides (≥150 
mg/dL), and low, HDL (<40 mg/dL for men and <50 mg/dL for 
women). A score of ≥ 1 was considered having dyslipidemia. 
Hypertension was computed as a binary variable where 
systolic blood pressure ≥ 140 mmHg or diastolic blood 
pressure ≥ 90 mmHg. 
Adjustment variables
Clinically significant covariates and potential confounders 
were tested with Pearson’s and Spearmen Rho’s correlations. 
All variables were retained for full models except marital 
status. Categories for education were collapsed to three: < 
high school, high school, > high school to assure sufficient 
power based on the estimated marginal means. A variable 
for physical activity: moderate or vigorous physical activity 
was computed by adding the yes and no responses for each 
category, then forming a binary variable for engaging in 
either moderate or vigorous physical activity. The income to 
poverty index was used to adjust for income. Health insurance 
was measured as a binary variable (yes/no). Smoking status 
was collapse to a binary variable, currently smoking (yes/no). 
In addition, variables for, gender (binary) and age in years 
(continuous) were used from the dataset.
Statistical analysis 
The general characteristics of the study population by race/
ethnicity were determined using complex sample design 
logistic regression models for categorical variables and 
general linear models for continuous variables with WNH 
as the reference group. Reduced and full logistic regression 
models were performed for each cardiometabolic risk factor. 
Reduced models included 1- and 2-way interactions of race/
ethnicity with each obesity indicator and were adjusted by 
age and gender. When no interaction was present, the 2-way 
term was dropped to achieve optimal model fit. Full models 
included the covariates of the reduced models along with 
currently smoking, education, health insurance, income 
to poverty index, and physical activity. Adjusted sample 
weights were used to account for unequal probabilities 
of selection and nonresponse in the multistage stratified 
cluster sampling design used in NHANES to achieve unbiased 
national estimates. The sample weights used were based on 
the Mobile Examination Center (MEC) and were computed 
using the average of the 2-year sample weights for each cycle, 
as per guidelines set by NHANES [12,15]. Data analysis was 
conducted with the complex sampling module, IBM-SPSS 
version 20. The Wald F statistic was used to determine model 
significance for logistic regression analysis [16]. A P-value of 
<.05 was considered significant.
Results
Risk factors associated with obesity and obesity indicators by 
race/ethnicity are depicted in (Table 1). Compared to WNH, 
other racial/ethnic groups were younger, had lower incomes, 
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less education and a higher prevalence of not having health 
insurance. WNH had a higher prevalence of engaging in 
moderate or vigorous physical activity, but spent more hours 
of sedentary activity as compared to other ethnic/racial groups. 
Obesity indicators had different patterns by race/ethnicity; 
however, subscapular skinfold thickness was significantly 
higher for all groups as compared to WHN. Diabetes and 
hypertension were more prevalent in all groups as compared 
to WNH. High A1C (prediabetes and diabetes) was more 
prevalent in MA and BNH as compared to WNH. The percent 
of high non-HDL cholesterol was greater for MA and BNH as 
compared to WHN. The fully adjusted models maintained the 
same patterns as the reduced models.
Final reduced and fully adjusted logistic regression analyses 
(Models 1,2,3) for the effect of obesity indicator and race on 
cardiometabolic disease states are shown in (Table 2). There 
were differences by race for all cardiometabolic diseases 
tested; however, two-way interactions of race/ethnicity by 
each of the obesity indicators were not significant. Therefore, 
interactions are not presented in the final models. For each 
model, subscapular skinfold and waist circumference measures 
were significant obesity indicators associated with each 
cardiometabolic disease: hyperglycemia, dyslipidemia, and 
hypertension. BMI was associated with Model 1 (hyperglycemia), 
only. Triceps skinfold thickness was not a significant indicator 
for the diseases tested. For (Model 1), subscapular skinfold 
thickness at the lowest quartile was 2.63 times less likely 
to have high A1C as compared to the highest quartile. The 
Odds Ratio for the lowest quartile subscapular skinfold 
thickness (0.38) represents the decrease in likelihood for high 
A1C as compared to the Odds Ratio of 1.00 for the highest 
quartile) (Model 1). Waist circumference had a stronger 
association with high A1C than subscapular skinfold thickness 
(Model 1). The lowest quartile was 4.00 times less likely than 
the highest quartile to have high A1C (prediabetes or diabetes) 
(Model 1). BMI and triceps skinfold thickness were not 
significantly associated with high A1C (Model 1). Model 2 
(reduced and fully adjusted), depicts those in the lowest 
quartiles of waist circumference and subscapular skinfold 
thickness were more likely to have high non HDL-C than 
those in the highest quartiles (see Table 2 legend notes). Since 
hypertension and hyperglycemia are commonly associated 
with dyslipidemia, additional analyses were conducted. 
(Table 3) presents the final models with Odds Ratios of race/
ethnicity and obesity indicators for two models of dyslipidemia, 
Model A, non-HDL-C and Model B, HDL-C. Both the reduced 
Variable MA OH BNH WNH reference P-value
Continuous variables –mean (SE)
Age (years) 40.9(0.65)** 42.2(0.71)** 45.0(0.59)** 49.2(0.37) <.001
Income to poverty index 1.84(0.05)** 2.07(0.07)** 2.34(0.08)** 3.32(0.07) <.001
Glycated hemoglobin (%) 5.71(0.04)* 5.65(0.04) 5.84(0.03)** 5.56(0.02) <.001
Waist circumference (cm) 98.9(0.54) 96.7(0.68)* 99.7(0.53) 98.7(0.37) .016
Male (cm) 100.2(0.81)* 99.4(.94)* 98.3(0.62)* 102.5(0.42) <.001
Female (cm) 97.5(0.47)* 94.2(0.76) 100.9(0.70)** 95.1(0.49) <.001
Triceps skinfold thickness (mm) 19.0(0.34) 19.4(0.38) 20.5(0.29)* 19.3(0.20) .003
Subscapular skinfold thickness (mm) 22.5(0.31)** 22.3(0.34)** 23.3(0.36)** 20.5(0.18) <.001
Categorical variables –percent within race/ethnicity (SE)
Triceps (75th % >25.5 mm) 23.2(1.2) 24.8(1.7) 33.2(1.1)* 23.8(1.0) <.001
Subscapular (75th % >27.4 mm) 26.4(1.6)** 26.1(2.1)** 35.9(1.6)** 21.7(0.9) <.001
Body mass index (BMI ≥ 35 kg/m2) 18.3(0.9)** 17.3(1.4) 26.1(1.2) ** 16.4(1.6) <.001
Diabetes (A1C ≥6.5%) 10.1(1.0)** 8.4(0.8)** 12.3(0.7)** 6.8(0.6) <.001
Hyperglycemia (A1C ≥6.0%) 18.4(1.2)* 16.9(1.3) 26.6(1.3)** 14.8(1.0) <.001
High non-HDL-cholesterol (≥130mg/dL) 33.6(1.3)* 36.4(1.8) 45.7(1.3)** 37.0(0.7) <.001
Hypertension (yes) 19.8(1.5)** 21.6(1.6)** 39.5(1.3)** 32.3(1.0) <.001
Currently smoking (yes) 22.5(1.2)** 14.8(1.8) 21.6(1.7) 19.1(1.2) .001
No health insurance 51.4(1.8)** 36.0(3.1)** 25.7(1.4)** 13.4(0.7) <.001
Education <high school 51.9(1.6)** 37.6(2.4)** 26.1(1.8)** 13.7(1.4) <.001
Engage in moderate or vigorous physical activity (yes) 39.3(2.1)** 41.3(1.7)** 41.8(1.2)** 54.7(2.3) <.001
High sedentary activity >4 hours/day 44.3(2.5) ** 51.7(2.1)** *65.9(1.8) 72.8(1.2) <.001
Table 1. Major cardiometabolic risk factors of the study population by race/ethnicity.
Abbreviations: MA: Mexican American; OH: other Hispanic; BNH: Black non-Hispanic; WNH: White non-Hispanic; A1C: 
glycated hemoglobin (hemoglobin A1c).
Notes: Continuous variables were reported as weighted means (SE). Categorical variables were reported as population percent 
(SE). P-values test the differences by race/ethnicity by the Wald F-statistic; asterisk symbols denote significant differences of 
each race/ethnicity as compared to White non-Hispanics (WNH). Income to poverty index is based on a scale (0-5) where 0-1 is 
below poverty, 1.0 is at poverty and other values measure relative distance from poverty. Non-HDL-cholesterol=non-high-density 
lipoprotein cholesterol. Pulse pressure was measured as the difference between the average systolic blood pressure and average 
diastolic blood pressure. 
* = P<.05; ** = P<.001.
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Dependent variables (disease state) Independent variables (risk factors) Reduced Models OR (95% CI) Full Models OR (95% CI)
Model 1. A1C ≥6.0 Race/ethnicity P<.001 P<.001
(Hyperglycemia) MA 2.58(1.94, 3.44) 1.94(1.39, 2.72)
OH 2.17(1.51, 3.12) 1.72(1.12, 2.66)
BNH 3.06(2.36, 3.99) 2.57(1.94, 3.41)
WNH (reference) 1.00 1.00
Subscapular skinfold thickness P<.001 P<.001
25th percentile 0.38(0.29, 0.52) 0.34(0.26, 0.45)
50th percentile 0.49(0.39, 0.60) 0.47(0.38,0.58) 
75th percentile 0.72(0.57, 0.92) 0.68(0.51, 0.90)
>75th percentile (reference) 1.00 1.00
Triceps skinfold thickness ns (P=.195) ns (P=.460)
BMI (P=.041) (P=.020)
< 25 kg/m2 0.61(0.40, 0.94) 0.56(0.36, 0.87)
25-29.9 kg/m2 0.60(0.43, 0.84) 0.57(0.41, 0.79)
30-34.9 kg/m2 0.74(0.55, 1.00) 0.74(0.54, 1.03)
≥ 35 kg/m2 (reference) 1.00 1.00
Waist circumference P<.001 P<.001
25th percentile 0.25(0.16, 0.38) 0.28(0.19, 0.43)
50th percentile 0.52(0.39, 0.68) 0.57(0.42, 0.76)
75th percentile 0.64(0.50, 0.82) 0.68( 0.51, 0.90)
>75th percentile (reference) 1.00 1.00 
Table 2. Likelihood for cardiometabolic diseases by race/ethnicity and obesity indicators.
MA: Mexican American; OH: other Hispanic; BNH: Black non-Hispanic; WNH: White non-Hispanic; A1C: glycated 
hemoglobin (hemoglobin A1c); BMI: body mass index. 
Notes: Reduced models included race/ethnicity and obesity indicators, and were adjusted for age and gender; full 
models included variables in the reduce model with additional adjustments for smoking, health insurance, education, 
income to poverty index, and physical activity. Model 2 suggests possible confounders, such as cholesterol-lowing 
medications, and individual variation may have influenced the relationship of level of obesity and presents of high 
non-HDL-C.  Cholesterol medication variables were available not for the entire sample. A model was run with this 
limited sample (n=2317). The adjustment did not change the direction of obesity indicators; the lowest quartiles of 
obesity indicator were still associated with an increased likelihood of high non-HDL-C.
Model 2. Non-HDL-C ≥130 mg/dL Race/ethnicity P<.001 P<.001
(Dyslipidemia) MA 0.90(0.78, 1.02) 0.92(0.78, 1.08)
OH 1.02(0.83, 1.26) 1.03(0.83, 1.27)
BNH 1.57(1.34, 1.84) 1.59(1.34, 1.88)
WNH (reference) 1.00 1.00
Subscapular skinfold thickness P<.001 P<.001
25th percentile 1.81(1.38, 2.37) 1.80(1.37, 2.38)
50th percentile 1.21(0.94, 1.55) 1.20(0.93, 1.56)
75th percent 0.94(0.80, 1.12) 1.59(1.34, 1.88)
>75th percent (reference) 1.00 1.00
Triceps skinfold thickness ns (P=.432) ns (P=.456)
BMI (kg/m2) ns P=.074 ns P=.062
Waist circumference P<.001 P<.001
25th percentile 1.55(1.12, 2.13) 1.51(1.09, 2.10)
50th percentile 0.84(0.61, 1.15) 0.83(0.61, 1.14)
75th percentile 0.77(0.63, 0.95) 0.76(0.62, 0.94)
>75th percentile (reference) 1.00 1.00
models and fully adjusted models include two measures 
of cardiometabolic diseases associated with dyslipidemia, 
hyperglycemia and hypertension. There were significant 
differences by race/ethnicity for these dyslipidemia indicators; 
however, the two-way interactions for race/ethnicity by 
each obesity indicator were not significant for both models. 
Therefore, interactions are not presented in the final models. 
Models with dyslipidemia measured as having at least one of 
the following: high non-HDL-C, low HDL-C, or high triglycerides 
did not achieve adequate fit and classification. This may 
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MA: Mexican American; OH: other Hispanic; BNH: Black non-Hispanic; WNH: White non-Hispanic; A1C: glycated 
hemoglobin (hemoglobin A1c.); BMI: body mass index. 
Notes: Reduced models included race/ethnicity and obesity indicators, and were adjusted for age and gender; full 
models included variables in the reduce model with additional adjustments for smoking, health insurance, education, 
income to poverty index, and physical activity. 
Table 2 (continued). Likelihood for cardiometabolic diseases by race/ethnicity and obesity indicators.
Dependent variables (disease state) Independent variables (risk factors) Reduced Models OR (95% CI) Full Models OR (95% CI)
Model 3. SBP ≥140 or DBP ≥ 90 Race/ethnicity P<.001 P<.001
mmHg (Hypertension ) MA 0.86(0.70, 1.04) 0.81(0.65, 1.01)
OH 0.84(0.69, 1.01) 0.80(0.64, 0.99
BNH 2.14, 1.73, 2.64) 2.03(1.66, 1.48)
WNH (reference) 1.00 1.00
Subscapular skinfold thickness P=.001 P=.001
25th percentile 0.64(0.52, 0.80) 0.64(0.51, 0.80)
50th percentile 0.78(0.64, 0.95) 0.78(0.64, 0.94)
75th percentile 0.97(0.79, 1.18) 0.96(0.79, 1.17)
>75th percent (reference) 1.00 1.00
Triceps skinfold thickness ns P=.264 ns P=.338
BMI ns P=.074 ns P=.062
Waist circumference P <.001 P<.001
25th percentile 0.42(0.30, 0.59) 0.44(0.32, 0.61)
50th percentile 0.62(0.43, 0.88) 0.64(046, 0.90)
75th percentile 0.81(0.59, 1.11) 0.83(0.61, 1.12)
>75th percentile (reference) 1.00 1.00
be due, in part, to the high percent of missing values for 
triglycerides. In addition, separate model were run for men 
and women for each measure of dyslipidemia; however, the 
patterns of significance were the same as for the combined 
model (data not shown).
Separate models of dyslipidemia measures (Models A and 
B) were conducted (Table 3). For Model A, individuals with 
hyperglycemia were more likely to have high non-HDL-C in 
both the reduced [OR=1.57(1.34, 1.83)] and the fully adjusted 
[OR= 1.60(1.37, 1.88] models. The Odds Ratios for high non-
HDL-C for persons with hypertension were greater than for 
people without hypertension in the reduced [1.25(1.06, 1.47)] 
and fully adjusted [1.24(1.06, 1.46)] models. BNH had a higher 
Odds Ratio of high non-HDL-C as compared to WNH in the 
reduced [1.45(1.24, 1.71)] and fully adjusted [1.49(1.25, 1.76)] 
models. Individuals in the lowest quartile of subscapular 
skinfold thickness were more likely to have high non-HDL-C 
as compared to those in the highest quartile in the reduced 
[OR=1.89(1.45, 2.47)] and fully adjusted [OR= 1.90(1.44, 2.49)] 
models. This unexpected, inverse relationship was found for 
waist circumference, as well, where the 1st quartile was more 
likely to have high non-HDL-C as compared to the 4th quartile 
for the reduced [OR=1.70(1.22, 2.36)] and fully adjusted 
[OR= 1.65(1.19, 2.30)] models. For Model B, low HDL-C, 
individuals with hyperglycemia were more likely to have 
low HDL-C in both the reduced [OR= 1.98(1.62, 1.78)] and 
fully adjusted [OR=1.78(1.47, 2.16)] models as compared to 
those with normal A1C. Low HDL-C was more likely for those 
with as compared to without hypertension for the reduced 
[OR=1.23(1.05, 1.45)] and fully adjusted [OR=1.21(1.03, 1.43)] 
models. BNH were less-likely to have low HDL-C as compared 
to WHN in the reduced [OR=0.53(0.42, 0.66)] and fully adjusted 
[OR=0.43(0.34, 0.55)] models. Individuals of normal BMI’s were 
significantly less likely to have low HDL-C than those with 
BMI’s ≥35 kg/m2. Persons with waist circumference in the 
25th and 50th percentiles were less likely to have low HDL-C 
as compared to the highest quartile (> 75th). Triceps skinfold 
thickness was not significant for any model and BMI was only 
significant in the fully adjusted model for HDL-C.
Discussion
Subscapular skinfold thickness and waist circumference were 
both significantly associated with hyperglycemia, dyslipidemia, 
and hypertension, independent of race/ethnicity. BMI was 
related to hyperglycemia, only. Triceps skinfold thickness 
was not associated with any of the cardiometabolic diseases. 
Adults in the under- and normal-weight categories were more 
likely to have high non-HDL-C. The findings suggest that 
obesity indicators may be an ineffective method of screening 
for dyslipidemia in normal weight adults. 
Additionally, our findings reconfirm racial/ethnic health 
disparities are still prevalent in the US. We found BNH to have 
the highest odds of having prediabetes/diabetes, dyslipidemia, 
and hypertension, as compared to WNH adjusting for obesity 
and sociodemographics. All groups (MA, OH, and BNH) 
had higher odds of prediabetes/diabetes as compared to 
WNH, adjusting for obesity and sociodemographics. Our 
results suggests measures of central obesity, such as waist 
circumference and subscapular skinfold measurements, are 
better indicators of cardiometabolic diseases than BMI or 
peripheral obesity (measured by triceps skinfold thickness) 
for a representative national sample of US adults across race/
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Models A and B A.  Dependent variable: high, non-HDL-C B. Dependent variable: low, HDL-C
Independent variables Reduced Model OR (95% CI) Full Model OR (95% CI) Reduced Model OR (95% CI) Full Model OR (95% CI)
Hyperglycemia 1.57(1.34, 1.83) 1.60(1.37, 1.88) 1.98(1.62, 2.42) 1.78(1.47, 2.16)
Hypertension 1.25(1.06, 1.47) 1.24(1.06, 1.46) 1.23(1.05, 1.45) 1.21(1.03, 1.43)
Race/ethnicity P <.001 P <.001 P <.001 P <.001
MA 0.86(0.076, 0.99) 0.91(0.78, 1.07) 1.13 (0.88, 2.46) 0.93(0.70, 1.23)
OH 0.99(0.79, 1.23) 1.00(0.81, 1.25) 0.98(0.80, 2.21) 0.81(0.66, 0.99)
BNH 1.45(1.24, 1.71) 1.49(1.25, 1.76) 0.53 (0.42, 0.66) 0.43(0.34, 0.55)
WNH (reference) 1.00 1.00 1.00 1.00
Subscapular skinfold thickness P <.001 P <.001 P <.001 P <.001
25th percentile 1.89(1.45, 2.47) 1.90(1.44, 2.49) 0.48(0.36, 0.63) 0.42(0.32, 0.57)
50th percentile 1.25(0.97, 1.60) 1.25(0.97, 1.61) 0.67(0.56, 0.80) 0.64(0.53, 0.76)
75th percentile 0.96(0.81, 1.13) 0.96(0.81, 1.14) 0.85(0.72, 1.02) 0.82(0.69, 0.98)
>75th percentile (reference) 1.00 1.00 1.00 1.00
Triceps skinfold thickness ns P=.244 ns P=.195 ns P=.887 ns P=.529
BMI (kg/m2) ns P=.377 ns P=.423 ns P=.151 P=.015
< 25 kg/m2 - - - 0.61(0.44, 0.85)
25-29.9 kg/m2 - - - 0.78(0.60, 1.02)
30-34.9 kg/m2 - - - 0.88(0.67, 1.18)
≥ 35 kg/m2 (reference) - - - 1.00
Waist circumference P <.001 P <.001 P <.001 P <.001
25th percentile 1.70(1.22, 2.36) 1.65(1.19, 2.30) 0.44(0.30, 0.63) 0.54(0.38, 0.76)
50th percentile 0.90(0.66, 1.24) 0.89(0.65, 1.22) 0.62(0.44, 0.88) 0.71(0.52, 0.97)
75th percentile 0.81(0.66, 0.99) 0.80(0.65, 0.99) 0.91(0.70, 1.18) 0.98(0.76, 1.26)
>75th percentile (reference) 1.00 1.00 1.00 1.00
Table 3. Effect of obesity indicators with hyperglycemia and hypertension on dyslipidemia.
Abbreviations: MA: Mexican American; OH: other Hispanic; BNH: Black non-Hispanic; WNH: White non-Hispanic; A1C: 
glycated hemoglobin (hemoglobin A1c); BMI: body mass index. 
Notes: Reduced models included prediabetes/diabetes (A1C ≥6.0), hypertension (SBP ≥140 or DBP ≥ 90 mmHg)
race/ethnicity and obesity indicators, and were adjusted for age and gender; full models included variables in the reduce 
model with additional adjustments for smoking, health insurance, education, income to poverty index, and physical activity.
ethnicity. However, caution needs to be exercises when using 
obesity indicators screening for dyslipidemia.
The obesity indicator that is most useful in screening adults 
for risk of diabetes, hypertension, and dyslipidemia has not 
been established. There is no concordance in the literature 
for an obesity indicator specific for each racial/ethnic group. 
Whether BMI or central obesity measures are more suitable 
indicators of CVD risk remains an area of disagreement. In a 
combined analysis of four longitudinal studies of Caucasians, 
there was no difference in central obesity compared to BMI 
in predicting diabetes and heart disease [17]. These results 
may not be applicable to Blacks and Hispanics. For example, 
MacKay et al., [18] found obesity indicators for African 
Americans to differ as compared to Hispanics and WNH using 
area under the receiver operating characteristic (AROC) curve 
(c-statistic) [18]. While central and overall obesity predicted 
the 5-year incidence of diabetes for other racial/ethnic groups, 
only central obesity predicted the incidence of diabetes for 
African Americans [18]. The investigators found subscapular 
to triceps ratio was the most predictive of diabetes for African 
Americans; while BMI was most predictive of diabetes for 
Hispanics and WNH [18]. Misra et al., [19] reviewed average 
values of waist circumference with associated CVD risk and 
found differences in optimal cutoff points by race/ethnicity. The 
authors attribute these differences to race/ethnic determinants 
of abdominal tissue that are influenced by the distribution of 
skeletal muscle, body fat, and bone [19]. For a population of 
multiracial children, combined CVD risk factors (serum lipids, 
fasting insulin, and blood pressure) prevalence was predicted 
by both BMI and skinfold sum (triceps and scapular) equally 
for the 85-94th percentile; albeit, the investigators noted BMI 
had a higher ratio for the comparison of ≥95th versus <25th 
percentiles [8]. Schubert et al., [20] reported that for adults, BMI, 
without bioelectric impedance correction, does not distinguish 
between fat and fat-free mass. In their longitudinal study of 
men and women, aged 40-60 years, there were significant 
increases in total cholesterol, low-density cholesterol, and 
triglycerides as fat-mass increased [20]. 
Skinfold thickness measurements have also been considered 
as an obesity indicator and markers for CVD risk including 
Vaccaro et al. Cardiovascular System 2013, 
http://www.hoajonline.com/journals/pdf/2052-4358-1-4.pdf
7
doi: 10.7243/2052-4358-1-4 
prediabetes and diabetes. In a review of obesity indicators of 
CVD risk, Snijder et al., [21] considered subscapular skinfold 
thickness to be a promising, simple indicator of central obesity 
citing several studies that found associations of skinfold 
thickness with high blood pressure and dyslipidemia. In a 
cohort of men, incidence of coronary heart disease after a 
12 year follow-up was associated with subscapular skinfold 
thickness, independent of BMI and adjusting for confounders 
[22]. Subscapular skinfold thickness, a measure of fat mass, was 
found to be a better predictor of CVD risk in cluster analysis 
as compared to BMI for Asian Indian adolescents [23]. Truncal 
skinfold thickness (subscapular, iliac and abdominal measures 
summed) was the sole predictor of plasma insulin after oral 
glucose tolerance test for adults across BMI categories for 
adults with prediabetes and diabetes [24]. The investigators 
recommend the use of skinfold thickness measure in screening 
for abnormal glucose or insulin [24]. Subscapular skinfold 
thickness, as compared to other obesity indicators (BMI, waist 
to hip ratio, waist circumference, abdominal measures, and 
other skinfold thickness measurements) was significantly 
higher for those with persistent impaired glucose tolerance 
(prediabetes) [25].
Our results indicating that obesity indicators may not be 
suitable for dyslipidemia screening have been supported by 
the literature. Low-density lipoprotein cholesterol (LDL-C) 
was not significantly associated with subcutaneous fat in 
normal weight Caucasian adults, neither for males nor for 
female [26]. The investigators found associations with visceral, 
but not subcutaneous fat related to blood lipids [26]. Kim 
et al., [27] found controlling for waist circumference did not 
influence the positive association between body fat mass and 
cardiometabolic risk factors (hyperglycemia and dyslipidemia) 
for Korean adults of normal body weight (measured by BMI 
adjusted for Asian body type). There were no significant 
prevalence rates for diabetes, hypertension, and dyslipidemia 
according to increasing BMI ≥35 kg/m2 for African Americans, 
adjusting for age and gender [28]. The authors suggest a 
lower range of BMI (30-34 kg/m2) may be expected for the 
likelihood of higher rates of these diseases [28].
This study has several strengths and weaknesses and 
the results should be interpreted in their context. A 
major strength of this investigation was the use of a large, 
nationally representative dataset. Another benefit of this 
study was the current comparison of minorities to WNH 
in areas of cardiometabolic risk factors with and without 
sociodemographic adjustments. Although efforts have been 
made to reduce health disparities, prevalence of health 
outcomes by race/ethnicity needs to be assessed every few 
years. The outcome chosen for race/ethnicity and obesity 
markers, non-HDL-C, may better reflect cardiometabolic risk 
than LDL-C according to a review by [29]. Several limitations 
were noted. The category “other races” was not used, due to 
a small sample size. Several variables were not used to adjust 
for individual differences. Atherogenic dyslipidemia, which 
includes small-dense LDL particles, was not measured; albeit 
non-HDL-C has been found to correlate more strongly with 
two indicators of atherogenic dyslipidemia, apoprotein (a) 
and small dense LDL particles [29]. Another limitation of this 
study was that cholesterol-lowering medication use was not 
available for the complete sample; however, in an analysis 
of the subsample where medication use was available, the 
pattern of significance was the same with or without this 
adjustment. Additionally, family history of high cholesterol 
was not available and may have been a confounder with 
obesity for non-HDL-C but not for HDL-C. The effect of obesity 
indicators in these dyslipidemia outcomes may be attributed 
to the fact that statins and other cholesterol medications 
seldom achieve improvement in HDL-C [30].
 
Conclusions
Although obesity indicators and cardiometabolic diseases 
differed by race/ethnicity; the effect of obesity indicators 
on these diseases were not influenced by race/ethnicity. 
Subscapular skinfold thickness and waist circumference, 
measures of central obesity, were positively associated 
with hyperglycemia, hypertension, and one measure of 
dyslipidemia, low-HDL. Conversely, both subscapular skin fold 
thickness and waist circumference had an inverse association 
with non-HDL-C, suggesting the presence of confounders. 
BMI was positively associated with hyperglycemia; however, 
relationships with non-HDL-C and HDL-C reduced models 
were not significant. There was a weak association of BMI and 
HDL-C in the fully adjusted model. Triceps skinfold thickness, 
a measure of peripheral body fat, was not associated with 
any of the assessed cardiometabolic disease. Subscapular 
skinfold measure should be considered as part of a screening 
for cardiometabolic diseases for adults in the US population.
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